|
CA2414772C
(en)
|
2000-07-07 |
2011-06-28 |
Jan Naslund |
Prevention and treatment of alzheimer's disease
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
BRPI0506629A
(pt)
|
2004-02-10 |
2007-05-02 |
Univ Colorado |
inibição do fator b, a via alternativa do sistema complemento e métodos relacionados
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
US7811563B2
(en)
*
|
2004-10-25 |
2010-10-12 |
Northwestern University |
Anti-addl antibodies and uses thereof
|
|
PT2343380T
(pt)
|
2004-11-16 |
2019-09-18 |
Humanigen Inc |
Permuta de cassetes da região variável de imunoglobulina
|
|
US7906625B2
(en)
*
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
WO2006128006A1
(en)
|
2005-05-26 |
2006-11-30 |
The Regents Of The University Of Colorado |
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
|
|
WO2007028146A2
(en)
*
|
2005-09-01 |
2007-03-08 |
Precision Therapeutics, Inc. |
Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
|
|
CN101291692A
(zh)
*
|
2005-10-21 |
2008-10-22 |
默克制药公司 |
抗addl单克隆抗体及其应用
|
|
US9133267B2
(en)
*
|
2005-11-22 |
2015-09-15 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of Alzheimer's and related diseases
|
|
US8691224B2
(en)
|
2005-11-30 |
2014-04-08 |
Abbvie Inc. |
Anti-Aβ globulomer 5F7 antibodies
|
|
HRP20140240T4
(hr)
|
2005-11-30 |
2017-02-24 |
Abbvie Inc. |
Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
|
|
EP1959996A2
(en)
|
2005-12-12 |
2008-08-27 |
AC Immune S.A. |
Monoclonal antibody
|
|
CN101325972B
(zh)
*
|
2005-12-12 |
2020-06-16 |
Ac免疫有限公司 |
具有治疗性质的Aβ1-42特异性单克隆抗体
|
|
KR20080097188A
(ko)
*
|
2006-02-24 |
2008-11-04 |
키에시 파르마슈티시 엣스. 피. 에이. |
항아밀로이드 면역성성분, 그 제조방법 및 용도
|
|
RU2429244C2
(ru)
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
|
MY153248A
(en)
*
|
2006-07-14 |
2015-01-29 |
Ac Immune Sa |
Humanized antibody against amyloid beta
|
|
EP2046833B9
(en)
|
2006-07-14 |
2014-02-19 |
AC Immune S.A. |
Humanized antibody against amyloid beta
|
|
EP3988566A1
(en)
*
|
2006-07-14 |
2022-04-27 |
AC Immune SA |
Humanized antibody against amyloid beta
|
|
SI2074145T1
(sl)
*
|
2006-10-02 |
2017-12-29 |
Ac Immune S.A. |
Humanizirano protitelo proti amiloid beta
|
|
PL2829551T3
(pl)
*
|
2006-10-19 |
2018-04-30 |
Csl Limited |
Antagonisty przeciwciała o wysokim powinowactwie wobec receptora alfa 1 interleukiny-13
|
|
CA2667067A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Merck & Co., Inc. |
Antibody antagonists of interleukin-13 receptor .alpha.1
|
|
AU2007319605B2
(en)
*
|
2006-10-19 |
2011-02-17 |
Csl Limited |
Anti-IL-13R alpha 1 antibodies and their uses thereof
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
TW200844110A
(en)
|
2007-01-11 |
2008-11-16 |
Univ Marburg Philipps |
Diagnosis and treatment of alzheimer's disease and other neurodementing diseases
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
JP5930573B2
(ja)
|
2007-03-01 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤の新規使用
|
|
CN101668773B
(zh)
|
2007-03-14 |
2016-08-31 |
亚力史制药公司 |
人工程化抗b因子抗体
|
|
EP2142514B1
(en)
|
2007-04-18 |
2014-12-24 |
Probiodrug AG |
Thiourea derivatives as glutaminyl cyclase inhibitors
|
|
WO2008148751A1
(en)
*
|
2007-06-04 |
2008-12-11 |
Vib Vzw |
Targeted induction of aggregation of proteins with cross beta structures
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
EP2009445A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
|
|
US8962677B2
(en)
|
2007-07-12 |
2015-02-24 |
Acumen Pharmaceuticals, Inc. |
Methods of restoring cognitive ability using non-peptidic compounds
|
|
US9006283B2
(en)
|
2007-07-12 |
2015-04-14 |
Acumen Pharmaceuticals, Inc. |
Methods of modifying amyloid β oligomers using non-peptidic compounds
|
|
US20100297013A1
(en)
*
|
2007-10-05 |
2010-11-25 |
Andrea Pfeifer |
Humanized antibody
|
|
AU2008311367B2
(en)
|
2007-10-05 |
2014-11-13 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
US20090104210A1
(en)
*
|
2007-10-17 |
2009-04-23 |
Tota Michael R |
Peptide compounds for treating obesity and insulin resistance
|
|
CN101965365A
(zh)
*
|
2007-10-19 |
2011-02-02 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
JP2011504371A
(ja)
|
2007-11-21 |
2011-02-10 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
抗第ｘｉ因子モノクローナル抗体およびその使用方法
|
|
US9217024B2
(en)
|
2007-12-18 |
2015-12-22 |
Acumen Pharmaceuticals, Inc. |
ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
EP2235058A2
(en)
|
2007-12-21 |
2010-10-06 |
Amgen, Inc |
Anti-amyloid antibodies and uses thereof
|
|
CN102936287B
(zh)
|
2008-02-08 |
2015-09-09 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
AT506819B1
(de)
|
2008-06-12 |
2011-06-15 |
Affiris Forschungs Und Entwicklungs Gmbh |
Vakzin zur behandlung von alzheimer-krankheit
|
|
US9085614B2
(en)
|
2008-08-01 |
2015-07-21 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to Aβ oligomers and uses thereof
|
|
SG2013061528A
(en)
*
|
2008-08-14 |
2015-03-30 |
Merck Sharp & Dohme |
Methods for purifying antibodies using protein a affinity chromatography
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
WO2011003098A1
(en)
|
2009-07-02 |
2011-01-06 |
Musc Foundation For Research Development |
Methods of stimulating liver regeneration
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
JP5599454B2
(ja)
*
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
SG177679A1
(en)
|
2009-08-07 |
2012-02-28 |
Kyowa Hakko Kirin Co Ltd |
Humanized anti-amyloid-b oligomer antibody
|
|
EP2463369A4
(en)
*
|
2009-08-07 |
2013-09-18 |
Kyowa Hakko Kirin Co Ltd |
HUMANIZED ANTIBODIES AGAINST AMYLOID B OLIGOMERS
|
|
KR101790802B1
(ko)
*
|
2009-09-03 |
2017-10-27 |
머크 샤프 앤드 돔 코포레이션 |
항-ｇｉｔｒ 항체
|
|
JP5934645B2
(ja)
|
2009-09-11 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
|
|
US8694430B2
(en)
*
|
2009-11-24 |
2014-04-08 |
Rakuten, Inc. |
Information processing device, information processing method, program and storage medium
|
|
US8961967B2
(en)
|
2009-11-30 |
2015-02-24 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
|
US10053513B2
(en)
|
2009-11-30 |
2018-08-21 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
|
TWI622402B
(zh)
|
2010-02-24 |
2018-05-01 |
免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
JP6026284B2
(ja)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤
|
|
NZ602312A
(en)
|
2010-03-10 |
2014-02-28 |
Probiodrug Ag |
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
|
WO2011149461A1
(en)
|
2010-05-27 |
2011-12-01 |
Medtronic, Inc. |
Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
|
|
US9176151B2
(en)
|
2010-07-14 |
2015-11-03 |
Acumen Pharmaceuticals, Inc. |
Antibodies, kit and method for detecting amyloid beta oligomers
|
|
EP2593475B1
(en)
*
|
2010-07-14 |
2016-03-02 |
Merck Sharp & Dohme Corp. |
Anti-addl monoclonal antibody and uses thereof
|
|
US9320793B2
(en)
*
|
2010-07-14 |
2016-04-26 |
Acumen Pharmaceuticals, Inc. |
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
|
EP2598882B1
(en)
|
2010-07-30 |
2017-07-26 |
AC Immune S.A. |
Safe and functional humanized antibodies for use in treating an amyloidosis
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
|
AU2011310664B2
(en)
*
|
2010-09-27 |
2016-02-18 |
Zestagen, S.A. |
Compositions and methods for treating neoplasia
|
|
MY164376A
(en)
*
|
2010-10-07 |
2017-12-15 |
Univ Leuven Kath |
Phosphospecific antibodies recognizing tau
|
|
SG191716A1
(en)
|
2010-11-19 |
2013-08-30 |
Toshio Imai |
Neutralizing anti-ccl20 antibodies
|
|
EP2686313B1
(en)
|
2011-03-16 |
2016-02-03 |
Probiodrug AG |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
|
BR112013025415B1
(pt)
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
KR20140072019A
(ko)
|
2011-07-13 |
2014-06-12 |
머크 샤프 앤드 돔 코포레이션 |
체액 샘플에서의 아밀로이드 베타 올리고머의 검출 방법 및 그의 용도
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
HUE034044T2
(en)
|
2011-09-30 |
2018-01-29 |
Dana Farber Cancer Inst Inc |
Therapeutic peptides
|
|
WO2013054110A2
(en)
*
|
2011-10-10 |
2013-04-18 |
University Of Lancaster |
Compositions for binding to amyloid proteins
|
|
CN107233569B
(zh)
|
2011-10-25 |
2021-08-31 |
普罗西纳生物科学有限公司 |
抗体制剂和方法
|
|
DE102011057019A1
(de)
*
|
2011-12-23 |
2013-06-27 |
Forschungszentrum Jülich GmbH |
Standard zur Quantifizierung von pathogenen Aggregaten aus körpereigenen Proteinen
|
|
US9377472B2
(en)
|
2012-04-30 |
2016-06-28 |
Amoneta Diagnostics |
Biological complex specific for Alzheimer's disease detection in vitro and use thereof
|
|
WO2013168164A1
(en)
|
2012-05-09 |
2013-11-14 |
Yeda Research And Development Co. Ltd. |
Variants of tace pro-domain as tnf-a inhibitor and their medical use
|
|
US9803005B2
(en)
|
2012-05-24 |
2017-10-31 |
Alexion Pharmaceuticals, Inc. |
Humaneered anti-factor B antibody
|
|
US9200073B2
(en)
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
SG11201506766PA
(en)
|
2013-03-15 |
2015-09-29 |
Dana Farber Cancer Inst Inc |
Therapeutic peptides
|
|
CN113150145B
(zh)
|
2013-08-30 |
2025-02-14 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
AU2014368696A1
(en)
|
2013-12-20 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Humanized anti-Tau(pS422) antibodies and methods of use
|
|
CA2939006A1
(en)
|
2014-03-14 |
2015-09-17 |
Dana-Farber Cancer Institute, Inc. |
Vaccine compositions and methods for restoring nkg2d pathway function against cancers
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
WO2016005466A2
(en)
|
2014-07-10 |
2016-01-14 |
Bioarctic Neuroscience Ab |
IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES
|
|
AU2016243126A1
(en)
*
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cells for the treatment of B7-H4 expressing solid tumors
|
|
WO2016160618A2
(en)
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
|
WO2016207245A1
(en)
|
2015-06-24 |
2016-12-29 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
|
CN116440279B
(zh)
|
2015-09-17 |
2026-02-24 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|
|
JP2017132742A
(ja)
*
|
2016-01-29 |
2017-08-03 |
国立大学法人 大分大学 |
Ａβオリゴマー特異的抗体の新規薬理用途
|
|
WO2017172733A1
(en)
*
|
2016-03-28 |
2017-10-05 |
The Regents Of The University Of California |
Anti-ryk antibodies and methods of using the same
|
|
CN110325547B
(zh)
|
2016-11-07 |
2023-12-26 |
德格克斯有限公司 |
新淀粉样蛋白β寡聚体特异性结合分子
|
|
US11840565B2
(en)
|
2016-12-29 |
2023-12-12 |
University Of Miami |
Methods and compositions for treating virus-associated inflammation
|
|
RU2019123160A
(ru)
|
2016-12-29 |
2021-01-29 |
Юниверсити Оф Майами |
Способ модуляции активности инфламмасом и воспаления в легком
|
|
ES2984844T3
(es)
*
|
2017-07-18 |
2024-10-31 |
Univ British Columbia |
Anticuerpos contra beta amiloide
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
EP4039274A1
(en)
*
|
2017-07-28 |
2022-08-10 |
Phanes Therapeutics, Inc. |
Anti-tim-3 antibodies and uses thereof
|
|
ES2812698T3
(es)
|
2017-09-29 |
2021-03-18 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
|
SG11202013176VA
(en)
*
|
2018-07-03 |
2021-01-28 |
Univ Miami |
Compositions and methods for treating inflammasome related diseases or conditions
|
|
CN111094340B
(zh)
*
|
2018-07-17 |
2022-11-22 |
江苏恒瑞医药股份有限公司 |
抗Abeta抗体、其抗原结合片段及应用
|
|
CN111217912B
(zh)
*
|
2018-11-26 |
2022-11-08 |
东莞市朋志生物科技有限公司 |
一种抗pgⅱ的抗体及其应用
|
|
US12365724B2
(en)
|
2018-12-10 |
2025-07-22 |
New York University |
Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 and methods of detecting thereof
|
|
WO2020160156A2
(en)
|
2019-01-30 |
2020-08-06 |
Immutics, Inc. |
Anti-gal3 antibodies and uses thereof
|
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Preparations containing the propeptide of lysyl oxidase and their uses
|
|
WO2020254670A1
(en)
*
|
2019-06-21 |
2020-12-24 |
Università Degli Studi Magna Graecia Catanzaro |
Monoclonal antibody targeting a unique cancer-associated epitope of cd43
|
|
CN114026109A
(zh)
*
|
2019-07-05 |
2022-02-08 |
株式会社岛津制作所 |
β淀粉样蛋白的单克隆抗体、和使用该抗体的β淀粉样蛋白相关肽的测定方法
|
|
US20230034474A1
(en)
*
|
2019-09-10 |
2023-02-02 |
Ac Immune Sa |
Novel Molecules for Diagnosis
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
MX2022011335A
(es)
*
|
2020-03-18 |
2022-10-07 |
Kindred Biosciences Inc |
Anticuerpos del receptor anti-interleucina 4 para uso veterinario.
|
|
EP4157338A4
(en)
|
2020-05-26 |
2024-11-13 |
TrueBinding, Inc. |
METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
|
|
CN112480250B
(zh)
*
|
2020-12-23 |
2022-03-15 |
上海交通大学 |
一种抗人骨桥蛋白的抗体及其应用
|
|
TW202300517A
(zh)
|
2021-03-12 |
2023-01-01 |
美商美國禮來大藥廠 |
抗類澱粉β抗體及其用途
|
|
WO2022251048A1
(en)
|
2021-05-24 |
2022-12-01 |
Eli Lilly And Company |
Anti-amyloid beta antibodies and uses thereof
|
|
US20240358805A1
(en)
*
|
2021-08-30 |
2024-10-31 |
The Brigham And Women's Hospital, Inc. |
Methods and materials to treat neurodegenerative disease
|
|
WO2023081766A2
(en)
*
|
2021-11-03 |
2023-05-11 |
Rutgers, The State University Of New Jersey |
Antibody-drug conjugates against the receptor tyrosine kinase epha5
|
|
CA3242060A1
(en)
*
|
2021-12-21 |
2023-06-29 |
Hbvtech, Llc. |
Methods for eliminating hepatitis b virus cccdna and rcdna and the hepatitis b drugs used in the methods thereof
|
|
EP4479075A1
(en)
|
2022-02-17 |
2024-12-25 |
Yeda Research and Development Co. Ltd |
Propeptide of lysyl oxidase for treatment of cancer
|
